{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:32:13Z","timestamp":1762101133412},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12032-011-9867-2","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T14:43:38Z","timestamp":1298990618000},"page":"1084-1092","source":"Crossref","is-referenced-by-count":10,"title":["PTEN\u2019s regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia"],"prefix":"10.1007","volume":"29","author":[{"given":"Cheng","family":"Zhiyong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wentong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xiaoyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"issue":"1","key":"9867_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/156800908783497122","volume":"8","author":"BH Jiang","year":"2008","unstructured":"Jiang BH, Liu LZ. AKT signaling in regulating angiogenesis. Curr Cancer Drug Targets. 2008;8(1):19\u201326.","journal-title":"Curr Cancer Drug Targets"},{"key":"9867_CR2","doi-asserted-by":"crossref","unstructured":"Ma J, Sawai H, Ochi N, et al. (2009) PTEN regulates angiogenesis through PI3K\/Akt\/VEGF signaling pathway in human pancreatic cancer cells. Mol Cell Biochem [Epub ahead of print].","DOI":"10.1007\/s11010-009-0154-x"},{"key":"9867_CR3","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1073\/pnas.040560897","volume":"97","author":"BH Jiang","year":"2000","unstructured":"Jiang BH, Zheng JZ, Aoki M, et al. Phosphatidylinositol 3- kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci USA. 2000;97:1749\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"9867_CR4","doi-asserted-by":"crossref","first-page":"9052","DOI":"10.1073\/pnas.94.17.9052","volume":"94","author":"MP Myers","year":"1997","unstructured":"Myers MP, Stolarov JP, Eng C, et al. PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA. 1997;94(17):9052\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5369","key":"9867_CR5","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1126\/science.280.5369.1614","volume":"280","author":"M Tamura","year":"1998","unstructured":"Tamura M, Gu J, Matsumoto K, et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science. 1998;280(5369):1614\u20137.","journal-title":"Science"},{"issue":"8","key":"9867_CR6","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1073\/pnas.081063798","volume":"98","author":"S Wen","year":"2001","unstructured":"Wen S, Stolarov J, Myers MP, et al. PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci USA. 2001;98(8):4622\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"9867_CR7","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1101\/gad.1308805","volume":"119","author":"K Hamada","year":"2005","unstructured":"Hamada K, Sasaki T, Koni PA, et al. The PTEN\/PI3\u00a0K pathway governs normal vascular development and tumor angiogenesis. Genes Dev. 2005;119(17):2054\u201365.","journal-title":"Genes Dev"},{"issue":"1","key":"9867_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5301\/JBM.2009.3178","volume":"24","author":"S Mourah","year":"2009","unstructured":"Mourah S, Porcher R, Lescaille G, et al. Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia. Int J Biol Markers. 2009;24(1):22\u201331.","journal-title":"Int J Biol Markers"},{"key":"9867_CR9","doi-asserted-by":"crossref","first-page":"30336","DOI":"10.1074\/jbc.273.46.30336","volume":"273","author":"HP Gerber","year":"1998","unstructured":"Gerber HP, Mcmurtrey A, Kowalski J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3\u2019-kinase\/Akt signal transduction pathway. Requirement for Flk-1\/KDR activation. J Biol Chem. 1998;273:30336\u201343.","journal-title":"J Biol Chem"},{"issue":"1","key":"9867_CR10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbapap.2007.09.008","volume":"1784","author":"BH Jiang","year":"2008","unstructured":"Jiang BH, Liu LZ. PI3K\/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta. 2008;1784(1):150\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"9867_CR11","doi-asserted-by":"crossref","unstructured":"Shafee N, Kaluz S, Ru N, et al. (2009) PI3K\/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines. Cancer Lett [Epub ahead of print].","DOI":"10.1016\/j.canlet.2009.03.004"},{"issue":"12","key":"9867_CR12","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.2337\/diabetes.52.12.2959","volume":"52","author":"J Cai","year":"2003","unstructured":"Cai J, Ahmad S, Jiang WG, et al. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes. 2003;52(12):2959\u201368.","journal-title":"Diabetes"},{"key":"9867_CR13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/B:APPT.0000045801.15585.dd","volume":"9","author":"M Osaki","year":"2004","unstructured":"Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis. 2004;9:667\u201376.","journal-title":"Apoptosis"},{"issue":"2","key":"9867_CR14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/hmg\/8.2.185","volume":"8","author":"PL Dahia","year":"1999","unstructured":"Dahia PL, Aguiar RC, Alberta J, et al. PTEN is inversely correlated with the cell survival factor Akt\/PKB and is inactivated via multiple mechanisms in haematological malignancies. Hum Mol Genet. 1999;8(2):185\u201393.","journal-title":"Hum Mol Genet"},{"key":"9867_CR15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jcp.20707","volume":"209","author":"C Xia","year":"2006","unstructured":"Xia C, Meng Q, Cao Z, et al. Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression. J Cell Physiol. 2006;209:56\u201366.","journal-title":"J Cell Physiol"},{"key":"9867_CR16","first-page":"3585","volume":"63","author":"JD Su","year":"2003","unstructured":"Su JD, Mayo LD, Donner DB, et al. PTEN and phosphatidylinositol 3\u2032-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment. Cancer Res. 2003;63:3585\u201392.","journal-title":"Cancer Res"},{"issue":"3","key":"9867_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000084547","volume":"74","author":"R Kobayashi","year":"2005","unstructured":"Kobayashi R, Saitoh O, Nakata H. Identification of adenosine receptor subtypes expressed in the human endothelial-like ECV304 cells. Pharmacology. 2005;74(3):143\u201351.","journal-title":"Pharmacology"},{"issue":"8","key":"9867_CR18","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1182\/blood-2004-03-0954","volume":"104","author":"GJ Roman","year":"2004","unstructured":"Roman GJ, Jimenez VA, Castillejo JA, et al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood. 2004;104(8):2492\u20138.","journal-title":"Blood"},{"issue":"9","key":"9867_CR19","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/sj.leu.2404740","volume":"21","author":"J Yang","year":"2007","unstructured":"Yang J, Liu J, Zheng J, et al. A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia. Leukemia. 2007;21(9):2072\u20134.","journal-title":"Leukemia"},{"issue":"8","key":"9867_CR20","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1182\/blood-2004-03-0954","volume":"104","author":"GJ Roman","year":"2004","unstructured":"Roman GJ, Jimenez VA, Castillejo JA, et al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood. 2004;104(8):2492\u20138.","journal-title":"Blood"},{"issue":"3","key":"9867_CR21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2141.2003.04452.x","volume":"122","author":"JW Cheong","year":"2003","unstructured":"Cheong JW, Eom JI, Maeng HY, et al. Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome. Br J Haematol. 2003;122(3):454\u20136.","journal-title":"Br J Haematol"},{"key":"9867_CR22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438:820\u20137.","journal-title":"Nature"},{"issue":"8","key":"9867_CR23","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/1535-7163.MCT-06-0044","volume":"5","author":"QD Nguyen","year":"2006","unstructured":"Nguyen QD, Rodrigues S, Rodrigue CM, et al. Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts. Mol Cancer Ther. 2006;5(8):2070\u20137.","journal-title":"Mol Cancer Ther"},{"issue":"13","key":"9867_CR24","doi-asserted-by":"crossref","first-page":"10760","DOI":"10.1074\/jbc.M110219200","volume":"277","author":"J Huang","year":"2002","unstructured":"Huang J, Kontos CD. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem. 2002;277(13):10760\u20136.","journal-title":"J Biol Chem"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-9867-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-011-9867-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-9867-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T18:29:23Z","timestamp":1560018563000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-011-9867-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9867"],"URL":"https:\/\/doi.org\/10.1007\/s12032-011-9867-2","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}